Search company, investor...
Search

Founded Year

2016

Stage

Series A | Alive

Total Raised

$10.65M

Last Raised

$9.7M | 1 yr ago

About Proov

MFB Fertility empowers couples to take control of their fertility by providing them ways to measure reproductive hormones at home. The Proov test allows women to track progesterone and identify hormonal problems that cause infertility and miscarriage while identifying and treating issues faster and with less cost than fertility centers and IVF treatments.

Proov Headquarters Location

5485 Conestoga Court Suite 210

Boulder, Colorado, 80301,

United States

Proov's Product Videos

Confirm demo.png

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Proov's Products & Differentiation

See Proov's products and how their products differentiate from alternatives and competitors

  • Proov Confirm

    Only FDA cleared test to confirm ovulation

    Differentiation

    Proov Confirm tracks PdG which is the hormone release AFTER ovulation and the one that prepares the body for implantation and pregnancy. It is to be used in conjunction with a fertility tracking met… 

  • Subscribe to see more

    We're on a mission to enable every organization to make smarter decisions about tech. Whether it's finding a new game-changing vendor or understanding a new market, it's easier, faster and smarter with CB Insights. All made possible by the smartest, hardest-working team in tech. Subscribe to see more.

    Differentiation

    We're on a mission to enable every organization to make smarter decisions about tech. Whether it's finding a new game-changing vendor or understanding a new market, it's easier, faster and smarter with CB Insights. All made possible by the smartest, hardest-working team in tech. Subscribe to see more.

  • Subscribe to see more

    We're on a mission to enable every organization to make smarter decisions about tech. Whether it's finding a new game-changing vendor or understanding a new market, it's easier, faster and smarter with CB Insights. All made possible by the smartest, hardest-working team in tech. Subscribe to see more.

    Differentiation

    We're on a mission to enable every organization to make smarter decisions about tech. Whether it's finding a new game-changing vendor or understanding a new market, it's easier, faster and smarter with CB Insights. All made possible by the smartest, hardest-working team in tech. Subscribe to see more.

  • Subscribe to see more

    We're on a mission to enable every organization to make smarter decisions about tech. Whether it's finding a new game-changing vendor or understanding a new market, it's easier, faster and smarter with CB Insights. All made possible by the smartest, hardest-working team in tech. Subscribe to see more.

    Differentiation

    We're on a mission to enable every organization to make smarter decisions about tech. Whether it's finding a new game-changing vendor or understanding a new market, it's easier, faster and smarter with CB Insights. All made possible by the smartest, hardest-working team in tech. Subscribe to see more.

  • Subscribe to see more

    We're on a mission to enable every organization to make smarter decisions about tech. Whether it's finding a new game-changing vendor or understanding a new market, it's easier, faster and smarter with CB Insights. All made possible by the smartest, hardest-working team in tech. Subscribe to see more.

    Differentiation

    We're on a mission to enable every organization to make smarter decisions about tech. Whether it's finding a new game-changing vendor or understanding a new market, it's easier, faster and smarter with CB Insights. All made possible by the smartest, hardest-working team in tech. Subscribe to see more.

Research containing Proov

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Proov in 2 CB Insights research briefs, most recently on Aug 31, 2022.

Expert Collections containing Proov

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Proov is included in 6 Expert Collections, including Women's Health & Wellness.

W

Women's Health & Wellness

1,478 items

Startups focused on providing products and services catering to women's health and wellbeing.

B

Beauty & Personal Care

858 items

These startups aim to provide health treatments, diagnosis tools, and products that do not require a prescription or connection with a health professional to enhance personal wellbeing. This includes supplements, women's health maintenance, OTC medicines, and more.

M

Medical Devices

8,490 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

H

Health Monitoring & Diagnostics

2,624 items

Companies developing or offering products that aid in the assessment, screening, diagnosis, or monitoring of a person's state of health/wellness. Excludes companies focused solely on fitness/sports performance

D

Digital Health

13,114 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)

H

Health IT

7,901 items

Proov Patents

Proov has filed 5 patents.

The 3 most popular patent topics include:

  • Human female endocrine system
  • Menstrual cycle
  • Estranes
patents chart

Application Date

Grant Date

Title

Related Topics

Status

1/2/2020

7/13/2021

Human female endocrine system, Midwifery, Menstrual cycle, Obstetrics, Syndromes

Grant

Application Date

1/2/2020

Grant Date

7/13/2021

Title

Related Topics

Human female endocrine system, Midwifery, Menstrual cycle, Obstetrics, Syndromes

Status

Grant

Latest Proov News

Data localization in the US is here

Jul 15, 2022

Red state. Blue state. Cloud state. All politics are local – and as statewide abortion restrictions spark fear of law enforcement data subpoenas, all reproductive health data is political. Cloud providers are already facing new challenges as a result. Fertility app Proov knew how important the location of the servers where its data is stored would be, when the Supreme Court draft opinion presaging the overturning of Roe v. Wade was leaked in May. On Monday, Proov kicked off its data migration from AWS and Microsoft Azure to a consolidated new home: Google Cloud. Proov’s decision came down to having the most options for data storage in states that protect abortion rights in order to ward against possible subpoenas for the fertility-related data it stores. It turned out Nevada played a key role in the decision. The company wanted to make sure the sensitive data it handles is physically stored in a state that is unlikely to restrict abortion rights in the future. And it wanted at least one fallback in case state laws change. Both Google and AWS offer data center storage options in California and Oregon, which together issued a multistate commitment last month to defend access to reproductive health care. But Nevada was what tipped the scales toward Google. It was one additional option offered by Google, but not AWS, which Proov believes will be a safe home for its reproductive health data. “When you're talking two versus three viable options, it is significant,” Jeff Schell, Proov’s chief technology officer, told me. The move to Google Cloud will cost the company tens of thousands of dollars, and won’t necessarily save money in the long run, but Proov’s data subpoena concerns are warranted. “If a company houses data in an abortion-restricted state, that state could use the company's presence and in-state data storage facility to present an argument that the company should be compelled to turn over any data in response to a lawful subpoena or court order regarding suspected abortions,” said Bethany Corbin, senior counsel at Nixon Gwilt Law, who specializes in reproductive health tech law. Ultimately, companies handling reproductive health data should look beyond improving privacy and security measures. “They should be minimizing the amount of data they collect and only collecting what is minimally necessary,” Corbin said. There’s a lot more detail in the full story. Check it out. SPONSORED CONTENT FROM FROM SOUL MACHINES They created Digital People. Now they've made celebrities available as Digital Twins: Soul Machines co-founder and CEO Greg Cross and his co-founder Mark Sagar, Ph.D., FRSNZ are leading their Auckland and San Francisco-based teams to create AI-enabled Digital People to populate the internet, at first, and soon the metaverse. $52 billion only goes so far these days Roughly 11,000 chip industry insiders descended on San Francisco this week for one of the largest semiconductor conferences since the pandemic began. Aside from the typical business-related talks during the three-day schmooze-and-booze that is Semicon West, the $52 billion of chip subsidies Congress is weighing came up in discussions both on stage and on the sidelines. $52 billion sounds like lots of money. But for chip companies, it’s not, as Bernstein analyst Stacy Rasgon pointed out on a panel of financial analysts. “I don’t know if this is politically correct in this audience,” he said. “I’m going to say it anyways … for the entire U.S. semiconductor industry, this is a rounding error. Who cares?” At least one person does: Laurie Locascio , Under Secretary of Commerce for Standards and Technology. Locascio agreed the sum of cash itself wasn’t large but said that wasn’t the whole point. The cash on the table is a signal to the industry that the U.S. is committed to building out its chip manufacturing capacity in the long run. “If you look across the board at the money, compared to the industry size, this is a small amount, and it’s a small amount compared to what China is investing in their industry, which is enormous,” Locascio told Protocol in an interview. “But if the [Chips Act] doesn’t pass, it’s an indicator. Chip companies are getting attracted [by] offers and incentives from all over the world to put their fabs there. We have to be in that game, we have to show this industry that we care that the United States really is in this game.” Enterprise moves Over the past week Broadcom announced an executive departure, Microsoft created a new C-suite role, Intel poached talent from TSMC and more. Thomas Krause is going to be the new CEO of Citrix-Tibco . Krause was formerly president of Broadcom Software. Krause’s responsibilities will shift to CEO Hock Tan. Nicole Dezen is the newly created chief partner officer for Microsoft . Microsoft’s channel chief role, previously held by Rodney Clark , will be split into two leadership roles and overseen by Dezen. David Smith was named the new VP of channel sales for Microsoft . Smith will report to Dezen along with Julie Sanford, VP of go-to-market strategy and programs. Matt Hicks was named CEO of Red Hat . Hicks was previously executive vice president of head of products and technologies. Jim Hansen joined Redacted as CEO . Hansen was the co-founder and COO of Mandiant, which was acquired by Google earlier this year. Steve Pinkos joined Intel as senior director of security policy, the company told Protocol. Pinkos previously worked in the White House, the Department of Commerce and the U.S. House of Representatives. Sandy Hogan joined SADA as chief revenue officer . Hogan was formerly senior vice president of worldwide commercial and partner sales at VMWare and worked at Rackspace and Cisco prior to that. David McNeil joined Envoy as chief revenue officer . McNeil was formerly chief commercial officer at Tebra and head of North American sales for Hubspot.

Proov Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Proov Rank

  • When was Proov founded?

    Proov was founded in 2016.

  • Where is Proov's headquarters?

    Proov's headquarters is located at 5485 Conestoga Court, Boulder.

  • What is Proov's latest funding round?

    Proov's latest funding round is Series A.

  • How much did Proov raise?

    Proov raised a total of $10.65M.

  • Who are the investors of Proov?

    Investors of Proov include Gingerbread Capital, Portfolia, Hambrecht Ducera Growth Ventures, Lightship Capital, SteelSky Ventures and 4 more.

  • Who are Proov's competitors?

    Competitors of Proov include Oova and 4 more.

  • What products does Proov offer?

    Proov's products include Proov Confirm and 4 more.

You May Also Like

OvuSense Logo
OvuSense

OvuSense offers a fertility monitoring system including medical devices. It is based in Warwick, England.

Paloma Health Logo
Paloma Health

Paloma Health is a D2C vertically integrated healthcare company focused on hypothyroidism. The Paloma Treatment combines complete at-home thyroid test kits with continuous physician supervision and medical guidance to help treat and monitor Hypothyroidism. The company was founded in 2018 and is based in New York, New York.

Medicus AI Logo
Medicus AI

Medicus AI is an AI-based platform that explains and interprets blood tests and medical reports to provide personalized health tips, recommendations and lifestyle coaching.

tbd health Logo
tbd health

tbd health is an at-home, STI screening platform made for women.

Healthy.io Logo
Healthy.io

Healthy.io is a mobile health company turning smartphone cameras into medical devices. Its first product, Dip.io, is a clinically approved home urinalysis kit that effectively turns the smartphone into a clinical grade urinalysis device, enabling the layperson to conduct clinically required urine testing with a simple smartphone scan.

D
Deep Longevity

Deep Longevity is developing explainable artificial intelligence systems to track the rate of aging at the molecular, cellular, tissue, organ, system, physiological, and psychological levels. It is also developing systems for the emerging field of longevity medicine enabling physicians to make better decisions on the interventions that may slow down, or reverse the aging processes. Deep Longevity developed Longevity as a Service (LaaS)© solution to integrate multiple deep biomarkers of aging dubbed “deep aging clocks” to provide a universal multifactorial measure of human biological age.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.